- Home
- MRNA vs NYT Comparison
MRNA vs NYT Comparison
Compare MRNA & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NYT
- Stock Information
- Founded
- MRNA 2010
- NYT 1851
- Country
- MRNA United States
- NYT United States
- Employees
- MRNA N/A
- NYT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NYT Newspapers/Magazines
- Sector
- MRNA Health Care
- NYT Consumer Discretionary
- Exchange
- MRNA Nasdaq
- NYT Nasdaq
- Market Cap
- MRNA 10.9B
- NYT 9.3B
- IPO Year
- MRNA 2018
- NYT N/A
- Fundamental
- Price
- MRNA $24.47
- NYT $58.25
- Analyst Decision
- MRNA Hold
- NYT Buy
- Analyst Count
- MRNA 19
- NYT 6
- Target Price
- MRNA $43.50
- NYT $60.33
- AVG Volume (30 Days)
- MRNA 9.9M
- NYT 1.5M
- Earning Date
- MRNA 11-06-2025
- NYT 11-03-2025
- Dividend Yield
- MRNA N/A
- NYT 1.24%
- EPS Growth
- MRNA N/A
- NYT 19.25
- EPS
- MRNA N/A
- NYT 1.93
- Revenue
- MRNA $3,078,000,000.00
- NYT $2,661,490,000.00
- Revenue This Year
- MRNA N/A
- NYT $9.93
- Revenue Next Year
- MRNA $10.17
- NYT $6.51
- P/E Ratio
- MRNA N/A
- NYT $30.08
- Revenue Growth
- MRNA N/A
- NYT 7.88
- 52 Week Low
- MRNA $23.15
- NYT $44.83
- 52 Week High
- MRNA $79.96
- NYT $62.24
- Technical
- Relative Strength Index (RSI)
- MRNA 38.50
- NYT 49.48
- Support Level
- MRNA $23.78
- NYT $57.80
- Resistance Level
- MRNA $25.48
- NYT $59.55
- Average True Range (ATR)
- MRNA 1.09
- NYT 0.81
- MACD
- MRNA 0.05
- NYT -0.32
- Stochastic Oscillator
- MRNA 25.00
- NYT 16.92
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.